BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter net income of $31.2 million.

On a per-share basis, the Boston-based company said it had net income of 61 cents. Earnings, adjusted for non-recurring costs and restructuring costs, came to $1.04 per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 97 cents per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $336.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $322.9 million.

Haemonetics expects full-year earnings in the range of $3.90 to $4 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News